Palvella Therapeutics Inc (PVLA)

EBITDA Growth

-165.64%

Quarterly · Period ending:

PVLA logo

PVLA EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-165.64%
PVLA Quarterly EBITDA YoY % (86.27% → -165.64%)
High-resolution chart · PNG

PVLA ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Palvella Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-165.64%
-155.4663%
-314.6203%
119.965%
-160.5778%
-302.6574%
42.2557%
82.8922%
-166.2625%
86.275%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.